STOCK TITAN

Director at Enova (NYSE: ENVA) sells 20,000 shares

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Enova International, Inc. director Mark Tebbe reported an open-market sale of 20,000 shares of common stock on June 18, 2026. The shares were sold at a weighted average price of $201.368 per share in multiple trades executed between $200.325 and $202.26. Following this transaction, Tebbe directly holds 50,029 Enova shares.

Positive

  • None.

Negative

  • None.

Insights

Director executed a sizable but partial open-market share sale.

Director Mark Tebbe sold 20,000 Enova common shares in an open-market transaction at a weighted average price of $201.368 on June 18, 2026. The trade was executed across multiple prices ranging from $200.325 to $202.26.

After the sale, Tebbe continues to hold 50,029 shares directly, indicating this was a partial reduction rather than a full exit from his equity position. The filing does not reference any option exercises, tax withholdings, or 10b5-1 trading plans, so this appears as a straightforward discretionary sale based on the available information.

Insider TEBBE MARK
Role null
Sold 20,000 shs ($4.03M)
Type Security Shares Price Value
Sale Common stock, par value $0.00001 per share 20,000 $201.368 $4.03M
Holdings After Transaction: Common stock, par value $0.00001 per share — 50,029 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares sold 20,000 shares Open-market sale on June 18, 2026
Weighted average sale price $201.368 per share Open-market sale of Enova common stock
Post-transaction holdings 50,029 shares Shares directly held by Mark Tebbe after sale
Price range of trades $200.325–$202.26 per share Multiple executions within single sale transaction
Net shares sold 20,000 shares Net-sell direction per transaction summary
open-market sale financial
"reported an open-market sale of 20,000 shares of common stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
Common stock, par value $0.00001 per share financial
"security_title": "Common stock, par value $0.00001 per share""
transaction code "S" financial
"transaction_code_description": "Sale in open market or private transaction""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
TEBBE MARK

(Last)(First)(Middle)
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 600

(Street)
CHICAGO ILLINOIS 60604

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock, par value $0.00001 per share06/18/2026S20,000D$201.368(1)50,029D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $200.325 to $202.26. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
Sean Rahilly, attorney in fact06/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Enova (ENVA) disclose for director Mark Tebbe?

Enova disclosed that director Mark Tebbe sold 20,000 common shares. The sale occurred on June 18, 2026, as an open-market transaction. It involved Enova International, Inc. common stock, par value $0.00001 per share, according to the Form 4 filing.

At what price did Mark Tebbe sell Enova (ENVA) shares in this Form 4?

The weighted average sale price was $201.368 per Enova share. The transaction was executed in multiple trades, with individual prices ranging from $200.325 to $202.26, as detailed in the Form 4 footnote.

How many Enova (ENVA) shares does Mark Tebbe hold after the reported sale?

After the sale, Mark Tebbe directly holds 50,029 Enova shares. Before this Form 4 transaction, he held a larger position, and the 20,000-share open-market sale reduced but did not eliminate his direct ownership stake.

Was the Enova (ENVA) insider transaction a buy or a sell?

The reported insider transaction was a sale of Enova shares. Form 4 data classify it as an open-market sale, with transaction code "S" and direction marked as "sell," reflecting a net disposition of 20,000 common shares.

Did the Enova (ENVA) Form 4 mention a Rule 10b5-1 trading plan?

The Form 4 footnote does not mention a Rule 10b5-1 plan. It focuses on explaining that the sale occurred in multiple trades within a price range and offers to provide full trade details upon request to regulators or shareholders.